Who does it first? The uptake of medical innovations in the performance of thrombolysis on ischemic stroke patients in Germany: a study based on hospital quality data.
about
Isoquercetin Ameliorates Cerebral Impairment in Focal Ischemia Through Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Effects in Primary Culture of Rat Hippocampal Neurons and Hippocampal CA1 Region of Rats.Acute Ischemic Stroke Hospital Admissions, Treatment, and Outcomes in Poland in 2009-2013.
P2860
Who does it first? The uptake of medical innovations in the performance of thrombolysis on ischemic stroke patients in Germany: a study based on hospital quality data.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Who does it first? The uptake ...... ased on hospital quality data.
@ast
Who does it first? The uptake ...... ased on hospital quality data.
@en
type
label
Who does it first? The uptake ...... ased on hospital quality data.
@ast
Who does it first? The uptake ...... ased on hospital quality data.
@en
prefLabel
Who does it first? The uptake ...... ased on hospital quality data.
@ast
Who does it first? The uptake ...... ased on hospital quality data.
@en
P2093
P2860
P921
P1476
Who does it first? The uptake ...... ased on hospital quality data.
@en
P2093
Helmar C Lehmann
Holger Pfaff
Nadine Scholten
Ute Karbach
P2860
P2888
P356
10.1186/S13012-014-0196-7
P577
2015-01-13T00:00:00Z
P5875
P6179
1026555448